Nestlé agrees to sell its vitamin and supplements unit for about $1 billion, according to multiple reports. The planned divestment covers mainstream supplements operations, with proceeds stated at roughly $1 billion.
The sources provide the same headline figure but limited additional deal details in the excerpts provided. Reporting frames the move as a portfolio reshuffle, with Nestlé exiting or reducing exposure to the mainstream supplements category. The Economic Times and Investing.com both describe the transaction in similar terms and do not, in the supplied text, specify the buyer, timing, or whether the deal is subject to regulatory approval.
Across outlets, the emphasis is on the sale price and the business being divested. None of the provided summaries describe major differences in the transaction structure beyond the shared characterization of a unit sale valued at around $1 billion.
